Chimeric antigen receptor T cells targeting CD7 in a child with high-risk T-cell acute lymphoblastic leukemia
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chimeric antigen receptor T cells targeting CD7 in a child with high-risk T-cell acute lymphoblastic leukemia
Authors
Keywords
CD7, CAR-T cell, Child with high-risk T-cell acute lymphoblastic leukemia, Induction failure
Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 96, Issue -, Pages 107731
Publisher
Elsevier BV
Online
2021-05-07
DOI
10.1016/j.intimp.2021.107731
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Successful Anti-CLL1 CAR T-Cell Therapy in Secondary Acute Myeloid Leukemia
- (2020) Hui Zhang et al. Frontiers in Oncology
- Eradication of T-ALL cells by CD7 targeted universal CAR-T cells and initial test of ruxolitinib-based CRS management
- (2020) Shiqi Li et al. CLINICAL CANCER RESEARCH
- Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia
- (2019) David T Teachey et al. LANCET ONCOLOGY
- A safe and potent anti-CD19 CAR T cell therapy
- (2019) Zhitao Ying et al. NATURE MEDICINE
- How I Treat Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (T-ALL) and T-cell Lymphoblastic Lymphoma in Children
- (2019) David T Teachey et al. BLOOD
- Pre- and post-transplant minimal residual disease predicts relapse occurrence in children with acute lymphoblastic leukaemia
- (2018) Federica Lovisa et al. BRITISH JOURNAL OF HAEMATOLOGY
- Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapy
- (2018) Kris M. Mahadeo et al. Nature Reviews Clinical Oncology
- Functional Improvement of Chimeric Antigen Receptor Through Intrinsic Interleukin-15Ra Signaling
- (2018) Sushmita Nair et al. CURRENT GENE THERAPY
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Clinical impact of minimal residual disease in children with different subtypes of acute lymphoblastic leukemia treated with Response-Adapted therapy
- (2016) C-H Pui et al. LEUKEMIA
- Impact of pretransplant minimal residual disease on the post-transplant outcome of pediatric acute lymphoblastic leukemia
- (2016) Katsutsugu Umeda et al. PEDIATRIC TRANSPLANTATION
- Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy
- (2016) Hanren Dai et al. JNCI-Journal of the National Cancer Institute
- Minimal residual disease before and after transplantation for childhood acute lymphoblastic leukaemia: is there any room for intervention?
- (2014) Adriana Balduzzi et al. BRITISH JOURNAL OF HAEMATOLOGY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia
- (2012) Martin Schrappe et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started